FKBP15: A Protein Target for Cancer and Neurodegenerative Diseases
![Review Report on FKBP15 Target / Biomarker](https://silexon.ai/img/target-biomarker-review.jpg?a=1)
![Content of Review Report on FKBP15 Target / Biomarker](https://silexon.ai/img/target-biomarker-review-content.jpg?a=2)
FKBP15: A Protein Target for Cancer and Neurodegenerative Diseases
FKBP15 (PPP1R76), a protein encoded by the gene PPP1R76, is a key regulator of protein synthesis in cells. It plays a critical role in the intracellular signaling pathway known as the PIK/PKA pathway, which is involved in a wide range of physiological processes, including cell growth, differentiation, and survival. FKBP15 has also been implicated in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, it has become an attractive drug target for researchers to explore new treatments for these diseases.
The PIK/PKA pathway is a complex signaling pathway that is involved in the regulation of many cellular processes. It is a critical pathway for the development and maintenance of the cell's cytoskeleton, as well as for the regulation of cell signaling pathways. The pathway is composed of several proteins, including the protein FKBP15, which plays a critical role in regulating the activity of the protein PIKP (PKA).
PKA is a protein that is involved in the regulation of protein synthesis in cells. It consists of two subunits, a catalytic subunit (K) and an regulatory subunit (R), which work together to regulate the activity of other proteins. The catalytic subunit of PKA is responsible for the catalytic activity of the pathway, while the regulatory subunit is responsible for regulating the activity of the catalytic subunit.
FKBP15 is a protein that is encoded by the gene PPP1R76. It is a key regulator of the PKA pathway, and it plays a critical role in the regulation of protein synthesis in cells. FKBP15 functions by interacting with the regulatory subunit of PKA, known as protein kinase (PK), and by inhibiting the activity of PK, it prevents the catalytic subunit of PKA from activating its catalytic activity.
FKBP15 has been shown to play a critical role in the regulation of cellular processes, including cell growth, differentiation, and survival. It has been shown to regulate the activity of several transcription factors, including transcription factor PKCJ2, which is involved in the regulation of cellular processes such as cell growth, differentiation, and survival. FKBP15 has also been shown to play a critical role in the regulation of cell signaling pathways, including the regulation of the PI3K/AKT signaling pathway, which is involved in the regulation of cellular processes such as cell growth, differentiation, and survival.
In addition to its role in the regulation of cellular processes, FKBP15 has also been implicated in the development and progression of several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that FKBP15 is involved in the regulation of the development and progression of cancer, and that its inhibition may be a potential therapeutic approach for cancer treatment.
FKBP15 has also been shown to be involved in the regulation of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Studies have shown that FKBP15 is involved in the regulation of the production of neurotransmitters, which are involved in the regulation of cellular processes such as mood, appetite, and movement. Additionally, FKBP15 has been shown to play a critical role in the regulation of the immune system, which is involved in the regulation of cellular processes such as cell growth, differentiation, and survival.
As a result of its involvement in the regulation of cellular processes, FKBP15 has become an attractive drug target for researchers to explore new treatments for diseases. Studies have shown that inhibiting the activity of FKBP15 may be a
Protein Name: FKBP Prolyl Isomerase Family Member 15
Functions: May be involved in the cytoskeletal organization of neuronal growth cones. Seems to be inactive as a PPIase (By similarity). Involved in the transport of early endosomes at the level of transition between microfilament-based and microtubule-based movement
The "FKBP15 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FKBP15 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
FKBP1A | FKBP1A-SDCBP2 | FKBP1B | FKBP1C | FKBP2 | FKBP3 | FKBP4 | FKBP5 | FKBP6 | FKBP7 | FKBP8 | FKBP9 | FKBP9P1 | FKBPL | FKRP | FKSG29 | FKTN | FLACC1 | FLAD1 | FLCN | FLG | FLG-AS1 | FLG2 | FLI1 | FLII | FLJ12825 | FLJ13224 | FLJ16779 | FLJ20021 | FLJ20712 | FLJ25758 | FLJ30679 | FLJ31945 | FLJ32154 | FLJ32255 | FLJ33534 | FLJ36000 | FLJ37201 | FLJ37786 | FLJ38576 | FLJ39095 | FLJ40194 | FLJ42393 | FLJ42627 | FLJ42969 | FLJ43315 | FLJ44342 | FLJ44635 | FLJ45513 | FLJ46875 | FLNA | FLNB | FLNC | FLOT1 | FLOT2 | FLRT1 | FLRT2 | FLRT3 | FLT1 | FLT3 | FLT3LG | FLT4 | FLVCR1 | FLVCR1-DT | FLVCR2 | FLVCR2-AS1 | FLYWCH1 | FLYWCH2 | FMC1 | FMC1-LUC7L2 | FMN1 | FMN2 | FMNL1 | FMNL2 | FMNL3 | FMO1 | FMO2 | FMO3 | FMO4 | FMO5 | FMO6P | FMO9P | FMOD | FMR1 | FMR1-AS1 | FMR1NB | FN1 | FN3K | FN3KRP | FNBP1 | FNBP1L | FNBP1P1 | FNBP4 | FNDC1 | FNDC10 | FNDC11 | FNDC3A | FNDC3B | FNDC4 | FNDC5